Development and Validation of a Novel Scoring Model Integrating Clinical Risk Factors and Pharmacokinetic Parameters to Predict Vancomycin‐Induced Nephrotoxicity | Synapse
March 3, 2026Open Access
Development and Validation of a Novel Scoring Model Integrating Clinical Risk Factors and Pharmacokinetic Parameters to Predict Vancomycin‐Induced Nephrotoxicity
Puntos clave
The scoring model may enhance prediction of vancomycin-induced nephrotoxicity, improving patient safety in clinical settings.
Using risk factors along with pharmacokinetic parameters, the model provides a new method for assessing nephrotoxicity risk.
Assessment integrates clinical data to tailor dosing strategies, which could lead to better patient outcomes and lower incidence of kidney injury.
The findings are significant for developing personalized medicine approaches, emphasizing the need for further validation in broader populations.
Resumen
The scoring model developed in the present study may enhance risk stratification for VCM-induced nephrotoxicity and contribute to advances in individualized dosing strategies in clinical practice.